Gabapentin enacarbil is an analgesic and anticonvulsant drug of the gabapentinoid class and a prodrug to gabapentin. This medication is used to treat moderate to severe restless legs syndrome. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection).
MARKET DYNAMICS
Factors contributing to the Gabapentin enacarbil market's growth include the high prevalence of neurological disorders among the population and increasing R & D in analgesic drugs. However, the side effects of the drug-like dizziness, drowsiness, and ataxia, can restrain the market growth.
MARKET SCOPE
The "Gabapentin Enacarbil Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of gabapentin enacarbil market with detailed market segmentation with type and application. The gabapentin enacarbil market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in gabapentin enacarbil market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The gabapentin enacarbil market is segmented on the basis of type and application. On the basis of type, the gabapentin enacarbil market is divided as capsule and tablet. Based on application, the gabapentin enacarbil market can be segmented into post-herpetic neuralgia (phn), restless legs syndrome (rls) and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the gabapentin enacarbil market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gabapentin enacarbil market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyses factors affecting gabapentin enacarbil market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the gabapentin enacarbil market in these regions.
MARKET PLAYERS
The report covers key developments in gabapentin enacarbil market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gabapentin enacarbil market are anticipated to have lucrative growth opportunities in the future with the rising demand for gabapentin enacarbil in the global market. Below mentioned is the list of few companies engaged in the gabapentin enacarbil market.
The report also includes the profiles of key players in gabapentin enacarbil market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Pfizer Inc.
- Glenmark Pharmaceuticals Limited
- Astellas Pharma Inc.
- AstraZeneca plc
- Aurobindo Pharma.
- Takeda Pharmaceutical Company Limited
- Intas Pharmaceuticals Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.